Your browser doesn't support javascript.
loading
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Thummalapalli, Rohit; Ricciuti, Biagio; Bandlamudi, Chaitanya; Muldoon, Daniel; Rizvi, Hira; Elkrief, Arielle; Luo, Jia; Alessi, Joao V; Pecci, Federica; Lamberti, Giuseppe; Di Federico, Alessandro; Hong, Lingzhi; Zhang, Jianjun; Heymach, John V; Gibbons, Don L; Plodkowski, Andrew J; Ravichandran, Vignesh; Donoghue, Mark T A; Vanderbilt, Chad; Ladanyi, Marc; Rudin, Charles M; Kris, Mark G; Riely, Gregory J; Chaft, Jamie E; Hellmann, Matthew D; Vokes, Natalie I; Awad, Mark M; Schoenfeld, Adam J.
Afiliación
  • Thummalapalli R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bandlamudi C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Muldoon D; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rizvi H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Elkrief A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Luo J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hong L; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ravichandran V; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Vanderbilt C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chaft JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Vokes NI; Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Schoenfeld AJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Clin Cancer Res ; 29(21): 4408-4418, 2023 11 01.
Article en En | MEDLINE | ID: mdl-37432985

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
...